{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:09:33Z","timestamp":1782522573407,"version":"3.54.5"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.08.107","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T10:45:45Z","timestamp":1505213145000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts"],"prefix":"10.1016","volume":"95","author":[{"given":"Julia","family":"Fedotova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kubatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"B\u00fcsselberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Shleikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Caprnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Dragasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Pohanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"Gasparova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Nosal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Opatrilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawar","family":"Qaradakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Zulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kruzliak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.08.107_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00115-013-3986-2","article-title":"Anxiety disorders in DSM-5: an overview on changes in structure and content","volume":"85","author":"Wittchen","year":"2014","journal-title":"Nervenarzt"},{"key":"10.1016\/j.biopha.2017.08.107_bib0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0015","first-page":"168","article-title":"Lifetime prevalence and age of onset distributions of mental disorders in the World Health Organization\u2019s World Mental Health Survey Initiative","volume":"6","author":"Kessler","year":"2007","journal-title":"World. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/fampra\/cmp071","article-title":"Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care","volume":"27","author":"Mart\u00edn-Merino","year":"2010","journal-title":"Fam. Pract."},{"key":"10.1016\/j.biopha.2017.08.107_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/070674370605100206","article-title":"Prevalence and incidence studies of anxiety disorders: a systematic review of the literature","volume":"51","author":"Somers","year":"2006","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.biopha.2017.08.107_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.biopsych.2014.08.006","article-title":"Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging","volume":"77","author":"Oathes","year":"2015","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.biopha.2017.08.107_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1162\/DAED_a_00319","article-title":"Feelings what are they & how does the brain make them?","volume":"144","author":"LeDoux","year":"2015","journal-title":"Daedalus"},{"key":"10.1016\/j.biopha.2017.08.107_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/11038128.2014.985607","article-title":"Health care professionals' experience-based understanding of individuals' capacity to work while depressed and anxious","volume":"22","author":"Bertilsson","year":"2015","journal-title":"Scand. J. Occup. Ther."},{"key":"10.1016\/j.biopha.2017.08.107_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1017\/neu.2014.23","article-title":"The Diagnostic Apathia Scale predicts the ability to return to work following depression or anxiety","volume":"26","author":"Hellstr\u00f6m","year":"2014","journal-title":"Acta. Neuropsychiatr."},{"key":"10.1016\/j.biopha.2017.08.107_bib0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.janxdis.2014.07.011","article-title":"Disseminating treatment for anxiety disorders: step 1: Recognizing the problem as a precursor to seeking help","volume":"28","author":"Coles","year":"2014","journal-title":"J. Anxiety. Disord."},{"key":"10.1016\/j.biopha.2017.08.107_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2014.11.004","article-title":"Correlates of comorbid depression, anxiety and helplessness with obsessive-compulsive disorder in Chinese adolescents","volume":"174","author":"Sun","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2017.08.107_bib0065","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1017\/S0033291710000176","article-title":"Functioning and disability levels in primary care out-patients with one or more anxiety disorders","volume":"40","author":"Sherbourne","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1176\/ps.2008.59.12.1383","article-title":"Depression and anxiety in the United States: findings from the 2006 behavioral risk factor surveillance system","volume":"59","author":"Strine","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.biopha.2017.08.107_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/070674370605100104","article-title":"Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics","volume":"51","author":"Schaffer","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0080","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"National comorbidity survey replication, the epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2017.08.107_bib0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0090","article-title":"Clinical practice guidelines: management of anxiety disorders","volume":"51","author":"Canadian Psychiatric Association","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/da.1070","article-title":"Infrequency of pure GAD: impact of psychiatric comorbidity on clinical course","volume":"14","author":"Bruce","year":"2001","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.biopha.2017.08.107_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2011.12.008","article-title":"Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA)","volume":"137","author":"Hofmeijer-Sevink","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2017.08.107_bib0105","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v65n0813","article-title":"Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder","volume":"65","author":"Boylan","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(01)00302-0","article-title":"The impact of comorbid anxiety disorders on the course of dysthymic disorder: a 5-year prospective longitudinal study","volume":"70","author":"Shankman","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2017.08.107_bib0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/da.20911","article-title":"Disorder-specific mental health service use for mood and anxiety disorders: associations with age, sex, and psychiatric comorbidity","volume":"29","author":"Mackenzie","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.biopha.2017.08.107_bib0120","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1592\/phco.23.12.1251.32700","article-title":"Comorbidities and associated treatment charges in patients with anxiety disorders","volume":"23","author":"McLaughlin","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biopha.2017.08.107_bib0125","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/archinte.166.19.2109","article-title":"Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions","volume":"166","author":"Sareen","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/da.10065","article-title":"Generalized anxiety disorder: prevalence, burden, and cost to society","volume":"16","author":"Wittchen","year":"2002","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.biopha.2017.08.107_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/j.1440-1614.2005.01510.x","article-title":"Disability, employment and work performance among people with ICD-10 anxiety disorders","volume":"39","author":"Waghorn","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0145","first-page":"165","article-title":"Anxiety disorders and GABA neurotransmission: a disturbance of modulation","volume":"11","author":"Nuss","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"April","key":"10.1016\/j.biopha.2017.08.107_bib0150","article-title":"Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment","author":"Locci","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2017.08.107_bib0155","first-page":"30352","article-title":"Elucidation of the neural circuits activated by a GABAB receptor positive modulator: relevance to anxiety","volume":"S0028\u2013S3908","author":"Pizzo","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"GABAA receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0165","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.1074\/jbc.M116.738906","article-title":"Toward understanding functional properties and subunit arrangement of \u03b14\u03b22\u03b4 \u03b3-Aminobutyric acid, type a (GABAA) receptors","volume":"291","author":"Wongsamitkul","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.08.107_bib0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2017.08.107_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-016-0668-3","article-title":"Long-Term pharmacological treatments of anxiety disorders: an updated systematic review","volume":"18","author":"Perna","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.biopha.2017.08.107_bib0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jclinane.2016.03.025","article-title":"Preoperative use of anxiolytic-sedative agents; are we on the right track","volume":"33","author":"Bucx","year":"2016","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.biopha.2017.08.107_bib0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1037\/a0040113","article-title":"Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: a randomized clinical trial","volume":"84","author":"Rosnick","year":"2016","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000155821.74832.f9","article-title":"A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder","volume":"25","author":"Mitte","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","article-title":"Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use","volume":"97","author":"Cunningham","year":"2010","journal-title":"Health. Policy"},{"key":"10.1016\/j.biopha.2017.08.107_bib0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell\u2019osso","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.euroneuro.2007.02.010","article-title":"Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats","volume":"17","author":"Nishikawa","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eurpsy.2010.10.006","article-title":"The adverse skeletal effects of selective serotonin reuptake inhibitors","volume":"27","author":"Tsapakis","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2013.05.050","article-title":"Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits","volume":"247","author":"Burghardt","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.08.107_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2009.07.083","article-title":"Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?","volume":"46","author":"Haney","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2017.08.107_bib0225","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.pnpbp.2010.09.013","article-title":"The age- dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review","volume":"35","author":"Olivier","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0230","first-page":"55","article-title":"Neurosteroids as neuromodulators in the treatment of anxiety disorders","volume":"19","author":"Longone","year":"2011","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2017.08.107_bib0235","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1177\/0269881110367726","article-title":"Opioids and anxiety","volume":"25","author":"Colasanti","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0240","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.2174\/138161212803530871","article-title":"Neuropeptides as therapeutic targets in anxiety disorders","volume":"18","author":"Lin","year":"2012","journal-title":"Curr. Pharm."},{"key":"10.1016\/j.biopha.2017.08.107_bib0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1517\/13543784.2013.803066","article-title":"Glutamate-based anxiolytic ligands in clinical trials","volume":"22","author":"Wiero\u0144ska","year":"2013","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1016\/j.biopha.2017.08.107_bib0250","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.npp.1301330","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats","volume":"32","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2017.08.107_bib0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/cn2000266","article-title":"Recent advances in the design and development of novel negative allosteric modulators of mGlu5","volume":"2","author":"Emmitte","year":"2011","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomoter activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0270","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","article-title":"Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats","volume":"514","author":"Pietraszek","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2015.01.005","article-title":"Pharmacology of acid-sensing ion channels \u2212 Physiological and therapeutical perspectives","volume":"94","author":"Baron","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nlm.2010.02.007","article-title":"Polyaminergic agents modulate contextual fear extinction in rats","volume":"93","author":"Gomes","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.biopha.2017.08.107_bib0290","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1016\/j.bmc.2013.09.011","article-title":"In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model","volume":"21","author":"Lewellyn","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2017.08.107_bib0295","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","article-title":"Animal models of anxiety disorders and stress","volume":"35","author":"Campos","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.biopha.2017.08.107_bib0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2015.17.3\/mbourin","article-title":"Animal models for screening anxiolytic-like drugs: a perspective","volume":"17","author":"Bourin","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0305","first-page":"1088","article-title":"Elevated plus maze for mice","volume":"22","author":"Komada","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2017.08.107_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0320","first-page":"3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2017.08.107_bib0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(03)01275-5","article-title":"The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines","volume":"463","author":"Millan","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0330","first-page":"1","article-title":"Complementary and alternative medicine use among adults and children: united States","volume":"12","author":"Barnes","year":"2008","journal-title":"2007 CDC National Health Statistics Report"},{"key":"10.1016\/j.biopha.2017.08.107_bib0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1475-2891-9-42","article-title":"Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review","volume":"9","author":"Lakhan","year":"2010","journal-title":"Nutr. J."},{"key":"10.1016\/j.biopha.2017.08.107_bib0340","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2007.07.023","article-title":"Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds","volume":"32","author":"Ognibene","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.biopha.2017.08.107_bib0345","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.lfs.2004.04.014","article-title":"Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders","volume":"75","author":"Zhang","year":"2004","journal-title":"Life. Sci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0350","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.lfs.2012.04.037","article-title":"Central pharmacological activity of a new piperazine derivative: 4-(1-Phenyl-1h-pyrazol-4- ylmethyl)-piperazine-1-carboxylic acid ethyl ester","volume":"90","author":"de Brito","year":"2012","journal-title":"Life. Sci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0355","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.phymed.2013.07.005","article-title":"Hypnotic, anticonvulsant and anxiolytic effects of 1-nitro-2-phenylethane isolated from the essential oil of Dennettia tripetala in mice","volume":"20","author":"Oyemitan","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2017.08.107_bib0360","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10517-015-3029-z","article-title":"Anxiolytic activity of diterpene alkaloid songorine","volume":"159","author":"Nesterova","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0365","first-page":"476","article-title":"Anxiolytic-like effect of ethanolic extract of Argemone mexicana and its alkaloids in Wistar rats","volume":"6","author":"Arcos-Mart\u00ednez","year":"2016","journal-title":"Avicenna. J. Phytomed."},{"key":"10.1016\/j.biopha.2017.08.107_bib0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jep.2013.03.002","article-title":"Antinociceptive, neurobehavioral and antioxidant effects of Eupatorium triplinerve Vahlonrats","volume":"147","author":"Melo","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fitote.2013.05.014","article-title":"Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells","volume":"89","author":"Russo","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2017.08.107_bib0380","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1742-7843.2010.00609.x","article-title":"Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol","volume":"107","author":"Guimar\u00e3es","year":"2010","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0385","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.foodchem.2012.09.028","article-title":"Antidepressant-like effects of fractions essential oil, carnosol and betulinic acid isolated from Rosmarinus officinalis L","volume":"136","author":"Machado","year":"2013","journal-title":"Food. Chem."},{"key":"10.1016\/j.biopha.2017.08.107_bib0390","first-page":"34","article-title":"Anxiolytic-like effects of phytol: possible involvement of GABAergic transmission","volume":"2014","author":"Costa","year":"1547","journal-title":"Brain. Res."},{"key":"10.1016\/j.biopha.2017.08.107_bib0395","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2014.07.007","article-title":"Anxiolytic-like effects and mechanism of (\u2212)-myrtenol: a monoterpene alcohol","volume":"579","author":"Moreira","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.08.107_bib0400","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00f6ve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0410","first-page":"91","article-title":"Evaluation of the anxiolytic and antidepressant effects of asiatic acid a compound from Gotu kola or Centella asiatica, in the male Sprague Dawley rat","volume":"83","author":"Ceremuga","year":"2015","journal-title":"AANA. J."},{"key":"10.1016\/j.biopha.2017.08.107_bib0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2015.03.077","article-title":"Anxiolytic-like effects of ursolic acid in mice","volume":"758","author":"Colla","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0420","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1472-8206.2009.00788.x","article-title":"Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission","volume":"24","author":"Melo","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0425","first-page":"344","article-title":"Evaluation of anxiolytic-like activity of Vitis vinifera juice in mice","volume":"6","author":"Aslam","year":"2016","journal-title":"Avicenna. J. Phytomed."},{"key":"10.1016\/j.biopha.2017.08.107_bib0430","doi-asserted-by":"crossref","first-page":"6530364","DOI":"10.1155\/2016\/6530364","article-title":"Involvement of 5-HT1A receptors in the anxiolytic-like effects of quercitrin and evidence of the involvement of the monoaminergic system","volume":"2016","author":"Li","year":"2016","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0435","doi-asserted-by":"crossref","first-page":"27695","DOI":"10.1038\/srep27695","article-title":"Luteolin inhibits GABAA receptors in HEK cells and brain slices","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.08.107_bib0440","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/0253-7613.182872","article-title":"The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice","volume":"48","author":"Pytka","year":"2016","journal-title":"Indian. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2014.11.003","article-title":"GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice","volume":"128","author":"Liu","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.08.107_bib0450","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5897\/AJPP2015.4488","article-title":"Anticonvulsant and anxiolytic activity of the leaf aqueous and ethanolic extracts of Melanthera scandens in a rat model","volume":"10","author":"Twinomujuni","year":"2016","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0455","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2156587216642101","article-title":"Effect of hydroalcoholic extract of Rosmarinus officinalis L. leaf on anxiety in mice","volume":"21","author":"Noori Ahmad Abadi","year":"2016","journal-title":"J. Evid. Based. Complementary. Altern. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0460","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1039\/C5FO00875A","article-title":"Mechanistic evidence of Passiflora edulis (Passifloraceae) anxiolytic activity in relation to its metabolite fingerprint as revealed via LC-MS and chemometrics","volume":"6","author":"Otify","year":"2015","journal-title":"Food. Funct."},{"key":"10.1016\/j.biopha.2017.08.107_bib0465","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jep.2015.01.029","article-title":"Interactions of a standardized flavonoid fraction from Tilia americana with Serotoninergic drugs in elevated plus maze","volume":"164","author":"Noguer\u00f3n-Merino","year":"2015","journal-title":"J.Ethnopharmacol"},{"key":"10.1016\/j.biopha.2017.08.107_bib0470","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2007.06.028","article-title":"Chlorogenic acid a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects","volume":"262","author":"Bouayed","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0475","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lfs.2007.05.007","article-title":"Anxiolytic-like effects of sinapic acid in mice","volume":"81","author":"Yoon","year":"2007","journal-title":"Life. Sci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0480","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/jsfa.7578","article-title":"p-Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities","volume":"96","author":"Pei","year":"2016","journal-title":"J. Sci. Food. Agric."},{"key":"10.1016\/j.biopha.2017.08.107_bib0485","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1089\/jmf.2010.1111","article-title":"Anxiolytic-like effects of 4-O-methylhonokiol isolated from Magnolia officinalis through enhancement of GABAergic transmission and chloride influx","volume":"14","author":"Han","year":"2011","journal-title":"J. Med. Food."},{"key":"10.1016\/j.biopha.2017.08.107_bib0490","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1179\/1476830515Y.0000000015","article-title":"Anxiolytic effects of sesamin in mice with chronic inflammatory pain","volume":"19","author":"Guo","year":"2016","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0495","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2014.11.016","article-title":"3,4,5-Trimethoxycinnamin acid ameliorates restraint stress-induced anxiety and depression","volume":"585","author":"Leem","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.08.107_bib0500","doi-asserted-by":"crossref","first-page":"e83243","DOI":"10.1371\/journal.pone.0083243","article-title":"Cinnamon counteracts the negative effects of a high fat\/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes","volume":"8","author":"Anderson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.107_bib0505","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pnpbp.2013.02.012","article-title":"Anxiolytic effects of Julibroside C1 isolated from Albizzia julibrissin in mice","volume":"44","author":"Jung","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2017.08.107_bib0510","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/13880200903280042","article-title":"Anxiolytic and sedative-hypnotic activities of polygalasaponins from Polygala tenuifolia in mice","volume":"48","author":"Yao","year":"2010","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0515","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10354-012-0164-2","article-title":"Characterization of anxiolytic and neuropharmacological activities of Silexan","volume":"163","author":"Kumar","year":"2013","journal-title":"Wien. Med. Wochenschr."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2017.08.107_bib0520","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/13651501.2013.813555","article-title":"An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review","volume":"17","author":"Kasper","year":"2013","journal-title":"Int. J. Psychiatry. Clin. Pract."},{"key":"10.1016\/j.biopha.2017.08.107_bib0525","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10354-010-0845-7","article-title":"Efficacy and safety of silexan a new, orally administered lavender oil preparation, in subthreshold anxiety disorder \u2212evidence from clinical trials","volume":"160","author":"Kasper","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.biopha.2017.08.107_bib0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phymed.2009.10.006","article-title":"A multi-center double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder","volume":"17","author":"Woelk","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2017.08.107_bib0535","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jep.2011.11.047","article-title":"Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract","volume":"140","author":"Baretta","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0540","series-title":"Assessment Report on Achillea Millefolium L., EMA\/HMPC\/149343\/2010","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.biopha.2017.08.107_bib0545","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2008.06.013","article-title":"GABA-A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts","volume":"56","author":"Benke","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0550","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-007-1037-z","article-title":"Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites","volume":"197","author":"Duarte","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2017.08.107_bib0555","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jep.2006.11.021","article-title":"Possible involvement of GABA A-benzodiazepine receptor in the anxiolytic-like effect induced by Passiflora actinia extracts in mice","volume":"111","author":"Lolli","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0560","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jep.2011.07.003","article-title":"The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass)","volume":"137","author":"Costa","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0565","first-page":"235","article-title":"Anti-anxiety Activity of methanolic extracts of different parts of Angelica archangelica Linn","volume":"3","author":"Kumar","year":"2011","journal-title":"J. Trad. Complement. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0570","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/2225-4110.114902","article-title":"Effect of Cissampelos pareira leaves on anxiety-like behavior in experimental animals","volume":"3","author":"Thakur","year":"2013","journal-title":"J. Trad. Complement. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0575","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2017.08.107_bib0580","doi-asserted-by":"crossref","first-page":"171","DOI":"10.32725\/jab.2006.019","article-title":"Expectations of biologically active compounds of the genus Magnolia in biomedicine","volume":"4","author":"Pato\u010dka","year":"2006","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.biopha.2017.08.107_bib0585","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1476-5381.2011.01456.x","article-title":"Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA\/benzodiazepine receptor complex in mice","volume":"164","author":"Chen","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2891-7-11","article-title":"Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial","volume":"7","author":"Kalman","year":"2008","journal-title":"Nutr. J."},{"key":"10.1016\/j.biopha.2017.08.107_bib0595","first-page":"323","article-title":"Soy isoflavones, lactobacilli Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause","volume":"58","author":"Mucci","year":"2006","journal-title":"Minerva. Ginecol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0600","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1021\/jm200186n","article-title":"Modulation of GABAA-receptors by honokiol and derivative: subtype selectivity and structure-activity relationship","volume":"54","author":"Taferner","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2017.08.107_bib0605","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jep.2009.05.040","article-title":"Interactions of Magnolia and Ziziphus extracts with selected central nervous system receptors","volume":"124","author":"Koetter","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0610","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuropharm.2005.04.009","article-title":"Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures","volume":"49","author":"Lin","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.08.107_bib0615","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1423-0127-16-94","article-title":"Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain","volume":"16","author":"Lin","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2017.08.107_bib0620","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2005.04.081","article-title":"Anxiolytic agent, dihydrohonokiol-B, recovers amyloid \u03b2 protein-induced neurotoxicity in cultured rat hippocampal neurons","volume":"384","author":"Liu","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.08.107_bib0625","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0253-7613.91869","article-title":"Anxiolytic activity of methanol leaf extract of Achyranthesaspera Linn in mice using experimental models of anxiety","volume":"44","author":"Barua","year":"2012","journal-title":"Indian. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0630","first-page":"450","article-title":"Anxiolytic and anticonvulsant activity of methanol extract of leaves of Alternanthera brasiliana (L.) Kuntze (Amaranthaceae) in laboratory animals","volume":"51","author":"Barua","year":"2013","journal-title":"Indian. J. Exp. Biol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0635","first-page":"969","article-title":"Anxiolytic effect of hydroethanolic extract of Drymariacordata L Willd","volume":"47","author":"Barua","year":"2009","journal-title":"Indian. J. Exp. Biol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0640","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jep.2007.01.009","article-title":"Anxiolytic effect of saponins from Panax quinquefolium in mice","volume":"111","author":"Wei","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0645","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1080\/13880209.2017.1310908","article-title":"Pharmacological evaluation of the anxiolytic-like effects of Lippia graveolens and bioactive compounds","volume":"55","author":"Gonz\u00e1lez-Trujano","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0650","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/13880209.2017.1285320","article-title":"Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats","volume":"55","author":"Rahmati","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0655","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11011-016-9914-y","article-title":"Effect of methanol extract of Trigonella foenum-graecum L. seeds on anxiety, sedation and motor coordination","volume":"32","author":"Assad","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2017.08.107_bib0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2017.02.023","article-title":"Anxiolytic- and antidepressant-like effects of an aqueous extract of Tanacetum parthenium L. Schultz-Bip (Asteraceae) in mice","volume":"22","author":"C\u00e1rdenas","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0665","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopha.2016.12.116","article-title":"The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorder","volume":"87","author":"Masoumi-Ardakani","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.08.107_bib0670","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jep.2016.11.016","article-title":"Antianxiety activity guided isolation and characterization of bergenin from Caesalpinia digyna Rottler roots","volume":"195","author":"Singh","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.08.107_bib0675","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1248\/bpb.b16-00694","article-title":"Xiao yao san improves the anxiety-Like behaviors of rats induced by chronic immobilization stress: the involvement of the JNK signaling pathway in the hippocampus","volume":"40","author":"Zhao","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2017.08.107_bib0680","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11418-016-1053-6","article-title":"Involvement of monoaminergic systems in anxiolytic and antidepressive activities of the standardized extract of Cocos nucifera L","volume":"71","author":"Lima","year":"2017","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0685","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14310\/horm.2002.1738","article-title":"Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized placebo-controlled, double-blind, crossover pilot study","volume":"16","author":"Kyrou","year":"2017","journal-title":"Hormones (Athens).7"},{"key":"10.1016\/j.biopha.2017.08.107_bib0690","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.phymed.2016.10.012","article-title":"Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial","volume":"23","author":"Mao","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2017.08.107_bib0695","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1515\/jcim-2015-0043","article-title":"A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression","volume":"13","author":"Mazidi","year":"2016","journal-title":"J. Complement Integr. Med."},{"key":"10.1016\/j.biopha.2017.08.107_bib0700","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2174\/1568026616666160204121039","article-title":"A systematic review of plant-derived natural compounds for anxiety disorders","volume":"16","author":"Farzaei","year":"2016","journal-title":"Curr. Top. Med. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217326380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217326380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:00:34Z","timestamp":1771401634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217326380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":140,"alternative-id":["S0753332217326380"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.107","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}